These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 3147010
1. An endocrine marker for pancreatic cancer. Tulassay Z, Sándor Z, Bodrogi L, Papp J, Fehér T. BMJ; 1988 Dec 03; 297(6661):1447-8. PubMed ID: 3147010 [No Abstract] [Full Text] [Related]
3. [Testosterone-dihydrotestosterone ratio in the differential diagnosis of pancreatic disease]. Sándor Z, Tulassay Z, Bodrogi L, Papp J, Szathmári M, Fehér T. Orv Hetil; 1989 Jun 25; 130(26):1387-8. PubMed ID: 2748159 [Abstract] [Full Text] [Related]
7. Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer. Boyd EJ, Rinderknecht H, Wormsley KG. Int J Pancreatol; 1988 May 25; 3(4):229-40. PubMed ID: 3290345 [No Abstract] [Full Text] [Related]
8. Androstanediol glucuronide in patients with pancreatic cancer and in those with chronic pancreatitis. Jansa R, Prezelj J, Kocijancic A, Osredkar J, Ferlic F. Horm Metab Res; 1996 Aug 25; 28(8):381-3. PubMed ID: 8886824 [Abstract] [Full Text] [Related]
11. Serum CA 242: the search for a valid marker of pancreatic cancer. Ventrucci M, Ubalducci GM, Cipolla A, Panella MA, Ligabue A. Clin Chem Lab Med; 1998 Mar 25; 36(3):179-84. PubMed ID: 9589807 [Abstract] [Full Text] [Related]
15. Androgen profile in patients with pancreatic carcinoma. Sperti C, Bonadimani B, Guolo P, Militello C, Cappellazzo F, Pasquali C, Pedrazzoli S. Ital J Gastroenterol; 1992 Oct 25; 24(6):328-31. PubMed ID: 1515658 [Abstract] [Full Text] [Related]
16. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis. Birk D, Gansauge F, Gansauge S, Formentini A, Lucht A, Beger HG. Int J Pancreatol; 1999 Apr 25; 25(2):89-96. PubMed ID: 10360220 [Abstract] [Full Text] [Related]
17. The value of routine biochemical tests in discriminating between malignant and benign pancreatic tumours. Athlin L, Blind PJ, Eriksson S. HPB Surg; 1991 Jun 25; 4(2):147-53; discussion 153-5. PubMed ID: 1931781 [Abstract] [Full Text] [Related]
18. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin. Yan T, Ke Y, Chen Y, Xu C, Yu C, Li Y. PLoS One; 2017 Jun 25; 12(4):e0174735. PubMed ID: 28369140 [Abstract] [Full Text] [Related]
19. Diagnostic pitfall; interpretation of CA 19-9 concentrations in the presence of hepatic dysfunction. Pearce S, Thornes H, Carr D, Tanner A. Gut; 1994 May 25; 35(5):707-8. PubMed ID: 8200572 [Abstract] [Full Text] [Related]
20. The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis. Harlozinska-Szmyrka A, Strutynska-Karpinska M. Gut; 2004 Mar 25; 53(3):469-70. PubMed ID: 14960539 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]